AZTA Stock Recent News

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass.

Azenta, Inc. (NASDAQ:AZTA ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Yvonne Perron - Vice President, Financial Planning & Analysis and Investor Relations John Marotta - President and Chief Executive Officer Lawrence Lin - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company, LLC Vijay Kumar - Evercore Inc. Paul Knight - KeyBanc Capital Markets Inc. Matthew Stanton - Jefferies Group LLC Brendan Smith - TD Cowen Operator Greetings, and welcome to the Azenta Q2 2025 Financial Results. During the presentation, all participants will be in a listen-only mode.

BURLINGTON, Mass. , May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025.

BURLINGTON, Mass. , April 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025, on Wednesday May 7, 2025, before the market opens.

BURLINGTON, Mass. , March 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities.

BURLINGTON, Mass. , March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y.

Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.

Azenta, Inc. (NASDAQ:AZTA ) Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ET Company Participants Yvonne Perron - Vice President, FP&A & Investor Relations John Marotta - President & Chief Executive Officer Lawrence Lin - Executive Vice President & Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens David Saxon - Needham & Company Vijay Kumar - Evercore ISI Matt Stanton - Jefferies Paul Knight - KeyBanc Capital Markets Andrew Cooper - Raymond James Operator Greetings and welcome to the Azenta Q1 2025 Financial Results Conference Call. During the presentation, all participants will be in a listen-only mode.

BURLINGTON, Mass. , Feb. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2024.

BURLINGTON, Mass. , Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held earlier today.